Shinichi Antoku

645 total citations
33 papers, 442 citations indexed

About

Shinichi Antoku is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology and Surgery. According to data from OpenAlex, Shinichi Antoku has authored 33 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Endocrinology, Diabetes and Metabolism, 15 papers in Nephrology and 8 papers in Surgery. Recurrent topics in Shinichi Antoku's work include Diabetes Treatment and Management (16 papers), Chronic Kidney Disease and Diabetes (12 papers) and Diabetes Management and Research (8 papers). Shinichi Antoku is often cited by papers focused on Diabetes Treatment and Management (16 papers), Chronic Kidney Disease and Diabetes (12 papers) and Diabetes Management and Research (8 papers). Shinichi Antoku collaborates with scholars based in Japan and United States. Shinichi Antoku's co-authors include Ito H, Michiko Togane, Mizuo Mifune, Mariko Abe, Yuichiro Takeuchi, Hidenori Ishida, Masahiro Shinozaki, Yuko Komatsu, Tsutomu Sanaka and Eiji Kusano and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes Research and Clinical Practice.

In The Last Decade

Shinichi Antoku

32 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shinichi Antoku Japan	13	203	168	97	93	92	33	442
Michiko Togane Japan	13	216 1.1×	197 1.2×	102 1.1×	94 1.0×	104 1.1×	31	464
Chun Gyoo Ihm South Korea	13	67 0.3×	174 1.0×	88 0.9×	73 0.8×	79 0.9×	40	432
Antonio Pacilli Italy	11	363 1.8×	331 2.0×	125 1.3×	104 1.1×	86 0.9×	16	656
Pin‐Ming Liu China	15	130 0.6×	76 0.5×	113 1.2×	111 1.2×	164 1.8×	50	563
Tom Manley United States	5	269 1.3×	235 1.4×	113 1.2×	84 0.9×	77 0.8×	6	509
Seiko Hoshino Japan	12	66 0.3×	187 1.1×	53 0.5×	119 1.3×	51 0.6×	23	395
Yume Nagaoka Japan	13	248 1.2×	283 1.7×	65 0.7×	51 0.5×	87 0.9×	39	569
Kumiko Totsuka Japan	5	166 0.8×	327 1.9×	66 0.7×	130 1.4×	48 0.5×	7	594
Amin Roshdy Soliman Egypt	12	93 0.5×	111 0.7×	91 0.9×	71 0.8×	32 0.3×	53	416
Eirini Lioudaki United Kingdom	12	138 0.7×	85 0.5×	96 1.0×	57 0.6×	83 0.9×	31	362

Countries citing papers authored by Shinichi Antoku

Since Specialization

Citations

This map shows the geographic impact of Shinichi Antoku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichi Antoku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichi Antoku more than expected).

Fields of papers citing papers by Shinichi Antoku

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichi Antoku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichi Antoku. The network helps show where Shinichi Antoku may publish in the future.

Co-authorship network of co-authors of Shinichi Antoku

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichi Antoku. A scholar is included among the top collaborators of Shinichi Antoku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichi Antoku. Shinichi Antoku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

H, Ito, Hiroji Ina, Shun Miura, et al.. (2024). Deterioration of the Defecation Status after Hospitalization in Patients with Type 2 Diabetes Is Associated with Albuminuria Rather Than Diabetic Neuropathy. Internal Medicine. 64(12). 1808–1819. 1 indexed citations

H, Ito, Hideyuki Inoue, Eiji Kusano, et al.. (2023). Anemia combined with albuminuria increases the risk of cardiovascular and renal events, regardless of a reduced glomerular filtration rate, in patients with type 2 diabetes: a prospective observational study. Diabetology International. 14(4). 344–355. 1 indexed citations

H, Ito, et al.. (2023). Changes in the estimated glomerular filtration rate and predictors of the renal prognosis in Japanese patients with type 2 diabetes: A retrospective study during the 12 months after the initiation of tofogliflozin. PLoS ONE. 18(9). e0292014–e0292014. 1 indexed citations

H, Ito, et al.. (2023). Relationship Between the Effect of Roxadustat and Comorbid Diabetes in Non-dialyzed Chronic Kidney Disease Patients: A Retrospective Observational Study. Cureus. 15(5). e39543–e39543. 1 indexed citations

H, Ito, Kiyoko Ito, Mari Tanaka, et al.. (2022). Constipation Is a Frequent Problem Associated with Vascular Complications in Patients with Type 2 Diabetes: A Cross-sectional Study. Internal Medicine. 61(9). 1309–1317. 8 indexed citations

H, Ito, Eiji Kusano, Jiro Kondo, et al.. (2021). Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation. PLoS ONE. 16(3). e0248577–e0248577. 6 indexed citations

H, Ito, et al.. (2020). The prognosis of subjects showing a reduced estimated glomerular filtration rate without albuminuria in Japanese patients with type 2 diabetes: a cohort study for diabetic kidney disease. Clinical and Experimental Nephrology. 24(11). 1033–1043. 4 indexed citations

H, Ito, et al.. (2020). Early Improvement of Non-islet Cell Tumor Hypoglycemia by Chemotherapy Using Lenvatinib in a Case with Type 2 Diabetes and Hepatocellular Carcinoma Producing Big IGF-II. Internal Medicine. 60(9). 1427–1432. 4 indexed citations

H, Ito, et al.. (2019). Changes in medication adherence and unused drugs after switching from daily dipeptidyl peptidase-4 inhibitors to once-weekly trelagliptin in patients with type 2 diabetes. Diabetes Research and Clinical Practice. 153. 41–48. 15 indexed citations

10.

H, Ito, et al.. (2019). <p>Comparison of the changes in the factors associated with the renal prognosis of non-elderly and elderly subjects treated with empagliflozin- a retrospective observation study in Japanese patients with type 2 diabetes</p>. Diabetes Metabolic Syndrome and Obesity. Volume 12. 1783–1794. 8 indexed citations

11.

H, Ito, Ayano Imai, Masahiro Shinozaki, et al.. (2016). Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013. Journal of Clinical Medicine Research. 8(10). 710–714. 3 indexed citations

12.

H, Ito, Shinichi Antoku, Mariko Abe, et al.. (2016). Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study. Internal Medicine. 55(22). 3247–3256. 9 indexed citations

13.

H, Ito, et al.. (2014). Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus. Drug Design Development and Therapy. 8. 391–391. 5 indexed citations

14.

H, Ito, Mariko Abe, Masahiro Shinozaki, et al.. (2013). Hypoglycemia Observed During Continuous Glucose Monitoring in Patients with Type 2 Diabetes Mellitus Treated by Subcutaneous Insulin Injection. Diabetes Technology & Therapeutics. 15(7). 586–590. 3 indexed citations

15.

H, Ito, Shinichi Antoku, Masahiro Shinozaki, et al.. (2013). The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease. SHILAP Revista de lepidopterología. 3(1). 66–72. 20 indexed citations

16.

H, Ito, Mizuo Mifune, Masahiro Shinozaki, et al.. (2013). Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis. Diabetes Therapy. 4(2). 321–329. 19 indexed citations

17.

H, Ito, Mizuo Mifune, Mariko Abe, et al.. (2012). The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus. Journal of Diabetes and its Complications. 26(4). 286–290. 23 indexed citations

18.

Takeuchi, Yuichiro, Ito H, Shinichi Antoku, et al.. (2012). Reduced endogenous insulin secretion in diabetic patients with low-titer positive antibodies against GAD. Journal of Diabetes Mellitus. 2(1). 96–100. 3 indexed citations

19.

H, Ito, Yuichiro Takeuchi, Hidenori Ishida, et al.. (2010). Mild anemia is frequent and associated with micro‐ and macroangiopathies in patients with type 2 diabetes mellitus. Journal of Diabetes Investigation. 1(6). 273–278. 23 indexed citations

20.

H, Ito, Hidenori Ishida, Yuichiro Takeuchi, et al.. (2010). Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus. Nutrition & Metabolism. 7(1). 83–83. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact